<VariationArchive VariationID="1735592" VariationName="NM_001022.4(RPS19):c.385dup (p.Arg129fs)" VariationType="Duplication" Accession="VCV001735592" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1790086" VariationID="1735592">
      <GeneList>
        <Gene Symbol="RPS19" FullName="ribosomal protein S19" GeneID="6223" HGNC_ID="HGNC:10402" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="41860255" stop="41872925" display_start="41860255" display_stop="41872925" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="42363987" stop="42375483" display_start="42363987" display_stop="42375483" Strand="+" />
          </Location>
          <OMIM>603474</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS19">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS19">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001022.4(RPS19):c.385dup (p.Arg129fs)</Name>
      <CanonicalSPDI>NC_000019.10:41869724:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="41869724" stop="41869725" display_start="41869724" display_stop="41869725" variantLength="1" positionVCF="41869724" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="42373794" stop="42373795" display_start="42373794" display_stop="42373795" variantLength="1" positionVCF="42373794" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>R134fs</ProteinChange>
      <ProteinChange>R129fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.41869727dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.41869727dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.42373797dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.42373797dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007080.3" sequenceAccession="NG_007080" sequenceVersion="3" change="g.14810dup">
            <Expression>NG_007080.3:g.14810dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001022.4" sequenceAccession="NM_001022" sequenceVersion="4" change="c.385dup" MANESelect="true">
            <Expression>NM_001022.4:c.385dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001013.1" sequenceAccession="NP_001013" sequenceVersion="1" change="p.Arg129fs">
            <Expression>NP_001013.1:p.Arg129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321483.2" sequenceAccession="NM_001321483" sequenceVersion="2" change="c.385dup">
            <Expression>NM_001321483.2:c.385dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308412.1" sequenceAccession="NP_001308412" sequenceVersion="1" change="p.Arg129fs">
            <Expression>NP_001308412.1:p.Arg129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321484.2" sequenceAccession="NM_001321484" sequenceVersion="2" change="c.385dup">
            <Expression>NM_001321484.2:c.385dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308413.1" sequenceAccession="NP_001308413" sequenceVersion="1" change="p.Arg129fs">
            <Expression>NP_001308413.1:p.Arg129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321485.2" sequenceAccession="NM_001321485" sequenceVersion="2" change="c.398dup">
            <Expression>NM_001321485.2:c.398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308414.1" sequenceAccession="NP_001308414" sequenceVersion="1" change="p.Arg134fs">
            <Expression>NP_001308414.1:p.Arg134fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1144" sequenceAccession="LRG_1144">
            <Expression>LRG_1144:g.14810dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1144t1" sequenceAccession="LRG_1144t1">
            <Expression>LRG_1144t1:c.385dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1144p1" sequenceAccession="LRG_1144p1" change="p.Arg129fs">
            <Expression>LRG_1144p1:p.Arg129fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001022.4(RPS19):c.385dup (p.Arg129fs) AND Diamond-Blackfan anemia" Accession="RCV002355538" Version="4">
        <ClassifiedConditionList TraitSetID="1756">
          <ClassifiedCondition DB="MedGen" ID="C1260899">Diamond-Blackfan anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-11-28" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25381059</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25946618</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3769971</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1756" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
                <XRef ID="88854002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blackfan Diamond syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anemia congenital erythroid hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aregenerative anemia chronic congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythrogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Red cell aplasia, pure hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hypoplastic anemia</ElementValue>
                <XRef ID="HP:0004810" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aase syndrome</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DBA</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDS</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6274" />
                <XRef ID="6274" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C1260899" DB="MedGen" />
              <XRef ID="D029503" DB="MeSH" />
              <XRef ID="MONDO:0015253" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004810" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005545" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8198255" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="17865569|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004409060" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25946618</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the RPS19 protein. Other variant(s) that result in a similarly extended protein product (p.Asp130Ser_fs*23) have been determined to be pathogenic (PMID: 25946618). This suggests that these extensions are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with RPS19-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the RPS19 gene (p.Arg129Lysfs*25). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 17 amino acid(s) of the RPS19 protein and extend the protein by 7 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.42373794_42373795insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5108273" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a834535|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002622840" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-04-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25381059</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3769971</ID>
          </Citation>
          <Comment>The c.385dupA pathogenic mutation, located in coding exon 4 of the RPS19 gene, results from a duplication of A at nucleotide position 385. This duplication occurs near the 3' terminus of RPS19 and result in the elongation of the protein by 7 amino acids (p.R129Kfs*25). This mutation perturbs a known motif responsible for signaling and interaction with chromatin, in addition to inserting extraneous residues into the constrained environment of the complex (Lorini et al. Eur. J. Pediatr 1986.;145(3):182-4; Downey et al.Mol. Cell Proteomics 2015;14(1):162-76). In addition, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS19" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001022.3:c.385dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8198255" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5108273" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

